Clinical Trial Update: CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA

View source ↗

Summary

This document reports an ongoing regulatory postmarketing surveillance study of capivasertib in Korea for breast cancer, sponsored by AstraZeneca, currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capivasertib (capivasertib)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Status: RECRUITING